Intermittent fasting for fatty liver disease in adults
Part of Digestive system clinical trials.
This study tests whether intermittent fasting can improve fatty liver disease (NAFLD) by reducing liver fat. It focuses on adults with confirmed fatty liver and extra liver fat seen on a special MRI scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older and able to sign informed consent
- Have a body mass index (BMI) between 23 and 30
- Have confirmed NAFLD from recent testing (biopsy or approved liver imaging within 6 months)
- Have liver fat level of at least 10% on an H-MRS scan during screening
- Test negative for hepatitis B and hepatitis C at screening
- Avoid heavy alcohol use for at least 3 months before screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two eating plans—intermittent fasting and the Mediterranean diet—to see which is better for people with fatty liver disease. If you qualify, you'll try one of these diets for a period, and the researchers will track changes in your liver health.
This study looks at whether changing when and how people eat can improve fatty liver disease caused by metabolic problems. It uses MRI to measure liver fat and compares outcomes while participants follow a structured eating schedule.
This study tests whether intermittent fasting (alternating periods of eating and fasting) can help with weight loss and health in adults with obesity. It aims to see if this approach is safe and effective.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
This study tracks how liver scarring (fibrosis) and fat buildup (steatosis) change over time in people with nonalcoholic fatty liver disease (NAFLD). It helps doctors understand risk factors so they can better predict and manage the disease.
This study tests whether eating within a limited time window each day can improve fatty liver disease (a buildup of fat in the liver). If you have moderate-to-advanced fatty liver disease and are overweight, this trial might help you learn if changing when you eat—rather than what you eat—can reduce liver fat and improve your health.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.